Salud Pública y Materno-Infantil
Departamento
![Foto de Salud Pública y Materno-Infantil](/img/noimage.png)
![Foto de University Hospital of Zurich](/img/noimage_org.png)
University Hospital of Zurich
Zúrich, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Zurich (14)
2024
-
Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)
Trials, Vol. 25, Núm. 1
-
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 1, pp. 275-286.e18
-
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Science Immunology, Vol. 9, Núm. 91
2023
-
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 984-996.e10
-
Adeno-associated virus 2 infection in children with non-A–E hepatitis
Nature, Vol. 617, Núm. 7961, pp. 555-563
-
Cerebral Oximetry Monitoring in Extremely Preterm Infants
New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511
-
Genomic investigations of unexplained acute hepatitis in children
Nature, Vol. 617, Núm. 7961, pp. 564-573
2021
-
Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
BMC Medical Research Methodology, Vol. 21, Núm. 1
-
Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown
Frontiers in Pediatrics, Vol. 9
2019
-
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease
Scientific Reports, Vol. 9, Núm. 1
-
Plasma lipid profiles discriminate bacterial from viral infection in febrile children
Scientific Reports, Vol. 9, Núm. 1
2013
-
Predictors of CD4+ T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes
Journal of Infectious Diseases, Vol. 207, Núm. 5, pp. 759-767
-
The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era
Clinical Infectious Diseases, Vol. 57, Núm. 7, pp. 1038-1047
2004
-
Congenital disorder of glycosylation (CDG) type Ie. A new patient
Journal of Inherited Metabolic Disease, Vol. 27, Núm. 5, pp. 591-600